ESR1 and breast cancer: Since ESR1 mutation is one of the main causes for endocrine therapy resistance, Dailey et al. designed an adenoviral ESR1 vaccine encoding ESR1 mutation forms and observed that vaccination effectively prevented the clinical emergence of ESR1mut + BC and the development of ESR1mut-mediated endocrine therapy resistance (Dailey et al., 2024).